On the Record · Intuitive Surgical
Intuitive Surgical acquisitions, on the record
The businesses Intuitive Surgical bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
Orpheus Medical Ltd. and its wholly owned subsidiariesWord for word“For example, in 2020, we acquired Orpheus Medical Ltd. and its wholly owned subsidiaries (“Orpheus Medical”) to deepen and expand our integrated informatics platform.” 10-K for 2023 | acquisition | 2020 | — |
da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, and San Marino, and associated territoriesWord for word“On January 21, 2025, Intuitive announced that it has entered into a definitive agreement with the current Intuitive technology distributors ab medica, Abex, Excelencia Robotica, and their affiliates to acquire the da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, and San Marino, and associated territories.” 10-K for 2024 | agreed acquisition | January 21, 2025 | — |
da Vinci distribution business of Chindex, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co. Ltd.Word for word“In 2019, the Joint Venture acquired certain assets related to the da Vinci distribution business of Chindex, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co. Ltd.” 10-K for 2024 | acquisition | 2019 | — |
Orpheus Medical Ltd. and its wholly owned subsidiaries (“Orpheus Medical”)Word for word“For example, in 2020, we acquired Orpheus Medical Ltd. and its wholly owned subsidiaries (“Orpheus Medical”) to deepen and expand our integrated informatics platform.” 10-K for 2024 | acquisition | 2020 | — |
a company that develops integrated robotics and artificial intelligence solutions for tissue assessment during biopsy proceduresWord for word“In November 2025, Intuitive acquired a company that develops integrated robotics and artificial intelligence solutions to improve the accuracy, efficiency, and accessibility of tissue assessment during biopsy procedures at the point of care.” 10-K for 2025 | acquisition | November 2025 | — |
da Vinci and Ion distribution businesses of ab medica, Abex, Excelencia Robotica, and their affiliates in Italy, Spain, Portugal, Malta, and San Marino, and associated territoriesWord for word“The transaction consists of an upfront cash payment of approximately € 319 million, subject to certain closing adjustments.” 10-K for 2025 | agreed acquisition | — | approximately € 319 million |
| Fiscal year ended | Cash paid for acquisitions (net of cash acquired) | Goodwill from acquisitions |
|---|---|---|
| 2016-12-31 | $0 | — |
| 2017-12-31 | $0 | — |
| 2018-12-31 | $87.9 million | $40.2 million |
| 2019-12-31 | $59.7 million | $65.4 million |
| 2020-12-31 | $37.7 million | $29.3 million |
| 2021-12-31 | $22.7 million | $8 million |
| 2022-12-31 | $12.8 million | $6.5 million |
| 2023-12-31 | $8.9 million | $0 |
| 2024-12-31 | $1 million | $0 |
| 2025-12-31 | $13.9 million | $22.3 million |
Deal filings since 2016
Read from Intuitive Surgical’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-03. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.